Virbac SAVirbac SAVirbac SA

Virbac SA

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.63 B‬EUR
16.0EUR
‪145.29 M‬EUR
‪1.40 B‬EUR
‪4.08 M‬
Beta (1Y)
0.37
Employees (FY)
‪5.62 K‬
Change (1Y)
+161 +2.95%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About Virbac SA


CEO
Paul Martingell
Website
Headquarters
Carros
Founded
1984
ISIN
FR0000031577
FIGI
BBG002G96476
Virbac SA engages in the manufacture and sale of veterinary medicines. It operates through the following business segments: Companion Animals and Farm Animals. It develops vaccines, antibiotics, anesthetics, dermatological products, and drugs for pest control, inflammation, dental care, and ophthalmological conditions of pets and livestock. It also operates through the following geographical segments: France, Europe, Latin America, North America, Asia, Pacific, and Africa and Middle-East. The Europe segment excludes France. The company was founded by Pierre-Richard Dick and Max Rombi in 1968 and is headquartered in Carros, France.

Check out other big names from the same industry as V16.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Virbac SA stocks are traded under the ticker V16.
We've gathered analysts' opinions on Virbac SA future price: according to them, V16 price has a max estimate of 420.00 EUR and a min estimate of 333.00 EUR. Watch V16 chart and read a more detailed Virbac SA stock forecast: see what analysts think of Virbac SA and suggest that you do with its stocks.
V16 reached its all-time high on Dec 14, 2021 with the price of 440.5 EUR, and its all-time low was 102.5 EUR and was reached on Nov 17, 2017. View more price dynamics on V16 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Virbac SA financials in yearly and quarterly reports right on TradingView.
Virbac SA is going to release the next earnings report on Mar 24, 2026. Keep track of upcoming events with our Earnings Calendar.
V16 net income for the last half-year is ‪82.41 M‬ EUR, while the previous report showed ‪50.62 M‬ EUR of net income which accounts for 62.79% change. Track more Virbac SA financial stats to get the full picture.
Yes, V16 dividends are paid annually. The last dividend per share was 1.45 EUR. As of today, Dividend Yield (TTM)% is 0.46%. Tracking Virbac SA dividends might help you take more informed decisions.
Virbac SA dividend yield was 0.46% in 2024, and payout ratio reached 8.36%. The year before the numbers were 0.37% and 9.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 28, 2025, the company has ‪5.62 K‬ employees. See our rating of the largest employees — is Virbac SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Virbac SA EBITDA is ‪260.07 M‬ EUR, and current EBITDA margin is 19.66%. See more stats in Virbac SA financial statements.
Like other stocks, V16 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Virbac SA stock right from TradingView charts — choose your broker and connect to your account.